Related content

Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response

By Palomba Stefano   Falbo Angela   Russo Tiziana   Orio Francesco   Tolino Achille   Zullo Fulvio  

Human Reproduction, Vol. 25, Iss. 4, 2010-04 ,pp. : 1005-1013

Oxford University Press

Access to resources Recommend Favorite

Should patients with polycystic ovary syndrome be treated with metformin?

By Stadtmauer Laurel A.   Wong Benjamin C.   Oehninger Sergio  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3016-3026

Oxford University Press

Access to resources Recommend Favorite

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

By Tang Thomas   Glanville Julie   Hayden Catherine J.   White Davinia   Barth Julian H.   Balen Adam H.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 80-89

Oxford University Press

Access to resources Recommend Favorite

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

By Genazzani Alessandro   Lanzoni Chiara   Ricchieri Federica   Baraldi Enrica   Casarosa Elena   Jasonni Valerio  

Gynecological Endocrinology, Vol. 23, Iss. 3, 2007-03 ,pp. : 146-152

Informa Healthcare

Access to resources Recommend Favorite